By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



5980 Horton Street
Suite 405
Emeryville  California  94608  U.S.A.
Phone: n/a Fax: n/a


Trianni is a privately held organization formed in 2010 with a mission to leverage recent advances in DNA synthesis and genomic modification technology toward development of an optimized therapeutic antibody discovery platform - The Trianni Mouse. The company is headquartered in the San Francisco Bay Area (CA, USA). For more information, please visit




Cofounder: Matthias Wabl, PhD

Key Statistics

Ownership: Private

Web Site: Trianni


Company News
Trianni Signs Agreement With Massachusetts General Hospital For Use Of The Trianni Mouse In HIV Vaccine Research 6/1/2017 6:39:45 AM
Trianni And Olympic Protein Technologies Sign License Agreement For The Trianni Mouse 5/24/2017 7:41:40 AM
Immunomic And Trianni Sign License Agreement For The Trianni Mouse 5/18/2017 9:15:11 AM
Trianni Signs Agreement With Magenta Therapeutics For Use Of The Trianni Mouse 3/22/2017 6:32:47 AM
Trianni Signs Collaboration Agreement With Fred Hutchinson Cancer Research Center For Use Of The Trianni Mouse Platform 3/8/2017 8:54:12 AM
Trianni Signs Agreement With Stanford University For Use Of The Trianni Mouse In Vaccine Research 2/22/2017 7:38:18 AM
Trianni Signs Licensing Agreement For TransGenic Mouse Platform Use With Janssen 2/15/2017 7:51:44 AM
ChemPartner And Trianni Announce Partnering Agreement 8/2/2016 7:28:17 AM
Trianni Announces Issuance Of Patent In China 6/9/2016 9:31:28 AM
Trianni CEO To Discuss Next Generation Of Fully Human Therapeutic Monoclonal Antibodies Designed To Reduce Time And Cost Of Antibody Isolation, Selection 5/24/2016 10:36:08 AM